scroll to top
0
Press enter or spacebar to select a desired language.
Press enter or spacebar to select a desired language.
Your source for trusted research content

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "PHARMACOGENOMICS"

1 - 10 of 19,247 results for
 "PHARMACOGENOMICS"
Press enter or spacebar to adjust the number of results displayed.

Pharmacogenomic analysis of a genetically distinct Indigenous population.

Publication Type: Academic Journal

Source(s): The pharmacogenomics journal [Pharmacogenomics J] 2022 Mar; Vol. 22 (2), pp. 100-108. Date of Electronic Publication: 2021 Nov 25.

Abstract: Indigenous Australians face a disproportionately severe burden of chronic disease relative to other Australians, with elevated rates of morbidity and mortality. While genomics technologies are slowly gaining momentum in personalised treatments for many...

Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.

Publication Type: Academic Journal

Source(s): Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Feb; Vol. 111 (2), pp. 366-372. Date of Electronic Publication: 2021 Jun 20.

Abstract: Aminoglycosides are widely used antibiotics with notable side effects, such as nephrotoxicity, vestibulotoxicity, and sensorineural hearing loss (cochleotoxicity). MT-RNR1 is a gene that encodes the 12s rRNA subunit and is the mitochondrial homologue o...

The PREPARE study: benefits of pharmacogenetic testing are unclear.

Publication Type: Editorial & Opinion

Source(s): Lancet (London, England) [Lancet] 2023 Jun 03; Vol. 401 (10391), pp. 1850-1851.

Authors:

The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply.

Publication Type: Editorial & Opinion

Source(s): Lancet (London, England) [Lancet] 2023 Jun 03; Vol. 401 (10391), pp. 1851-1852.

The PREPARE study: benefits of pharmacogenetic testing are unclear.

Publication Type: Editorial & Opinion

Source(s): Lancet (London, England) [Lancet] 2023 Jun 03; Vol. 401 (10391), pp. 1851.

Authors:

The PREPARE study: benefits of pharmacogenetic testing are unclear.

Publication Type: Editorial & Opinion

Source(s): Lancet (London, England) [Lancet] 2023 Jun 03; Vol. 401 (10391), pp. 1850.

Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.

Publication Type: Academic Journal

Source(s): Italian journal of pediatrics [Ital J Pediatr] 2023 May 18; Vol. 49 (1), pp. 57. Date of Electronic Publication: 2023 May 18.

Abstract: Background: Tacrolimus is the backbone drug in kidney transplantation. Single nucleotide polymorphism of Multidrug resistant 1 gene can affect tacrolimus metabolism consequently it can affect tacrolimus trough level and incidence of acute rejection. Th...

Can Pharmacogenetic Variants in TPMT , MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?

Publication Type: Academic Journal

Source(s): International journal of molecular sciences [Int J Mol Sci] 2023 May 10; Vol. 24 (10). Date of Electronic Publication: 2023 May 10.

Abstract: Systemic sclerosis (SSc) is a rare connective tissue disorder with highest morbidity and mortality among rheumatologic diseases. Disease progression is highly heterogeneous between patients, implying a strong need for individualization of therapy. Four...

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients.

Publication Type: Editorial & Opinion

Source(s): Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2023 May 06; Vol. 78, pp. 100214. Date of Electronic Publication: 2023 May 06 (Print Publication: 2023).

Abstract: Competing Interests: Conflicts of interest The authors declare no conflicts of interest.

Use of Pharmacogenomics to Guide Proton Pump Inhibitor Therapy in Clinical Practice.

Publication Type: Academic Journal

Source(s): Digestive diseases and sciences [Dig Dis Sci] 2021 Dec; Vol. 66 (12), pp. 4120-4127. Date of Electronic Publication: 2021 Jan 21.

Abstract: Prescribing the right medication, at the right dose, to the right patient is the goal of every physician. Pharmacogenomic information is an emerging tool that can be used to deliver precision medicine. In this review, we discuss the pharmacogenomics of...

sponsored